MyMD Pharmaceuticals (MYMD) Competitors $0.18 -0.06 (-25.44%) As of 04/17/2025 Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsInsider TradesOptions ChainOwnershipSEC FilingsTrendsBuy This Stock MYMD vs. PTPI, THAR, QLGN, GLMD, VCNX, PBM, PTIX, ELAB, ZVSA, and ENTOShould you be buying MyMD Pharmaceuticals stock or one of its competitors? The main competitors of MyMD Pharmaceuticals include Petros Pharmaceuticals (PTPI), Tharimmune (THAR), Qualigen Therapeutics (QLGN), Galmed Pharmaceuticals (GLMD), Vaccinex (VCNX), Psyence Biomedical (PBM), Protagenic Therapeutics (PTIX), Elevai Labs (ELAB), ZyVersa Therapeutics (ZVSA), and Entero Therapeutics (ENTO). These companies are all part of the "pharmaceutical products" industry. MyMD Pharmaceuticals vs. Petros Pharmaceuticals Tharimmune Qualigen Therapeutics Galmed Pharmaceuticals Vaccinex Psyence Biomedical Protagenic Therapeutics Elevai Labs ZyVersa Therapeutics Entero Therapeutics Petros Pharmaceuticals (NASDAQ:PTPI) and MyMD Pharmaceuticals (NASDAQ:MYMD) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their valuation, media sentiment, earnings, profitability, analyst recommendations, risk, community ranking, institutional ownership and dividends. Which has preferable valuation and earnings, PTPI or MYMD? MyMD Pharmaceuticals has lower revenue, but higher earnings than Petros Pharmaceuticals. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioPetros Pharmaceuticals$5.11M0.43-$8.16M-$4.76-0.01MyMD PharmaceuticalsN/AN/A-$4MN/AN/A Does the media refer more to PTPI or MYMD? In the previous week, Petros Pharmaceuticals had 1 more articles in the media than MyMD Pharmaceuticals. MarketBeat recorded 1 mentions for Petros Pharmaceuticals and 0 mentions for MyMD Pharmaceuticals. MyMD Pharmaceuticals' average media sentiment score of 0.00 beat Petros Pharmaceuticals' score of -1.00 indicating that MyMD Pharmaceuticals is being referred to more favorably in the news media. Company Overall Sentiment Petros Pharmaceuticals Negative MyMD Pharmaceuticals Neutral Do insiders and institutionals have more ownership in PTPI or MYMD? 12.3% of Petros Pharmaceuticals shares are owned by institutional investors. Comparatively, 9.6% of MyMD Pharmaceuticals shares are owned by institutional investors. 12.3% of Petros Pharmaceuticals shares are owned by insiders. Comparatively, 2.1% of MyMD Pharmaceuticals shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term. Is PTPI or MYMD more profitable? Petros Pharmaceuticals' return on equity of -78.22% beat MyMD Pharmaceuticals' return on equity.Company Net Margins Return on Equity Return on Assets Petros PharmaceuticalsN/A -78.22% -23.50% MyMD Pharmaceuticals N/A -179.05%-108.14% Does the MarketBeat Community favor PTPI or MYMD? Petros Pharmaceuticals received 1 more outperform votes than MyMD Pharmaceuticals when rated by MarketBeat users. CompanyUnderperformOutperformPetros PharmaceuticalsOutperform Votes1100.00% Underperform VotesNo VotesMyMD PharmaceuticalsN/AN/A Which has more volatility and risk, PTPI or MYMD? Petros Pharmaceuticals has a beta of 2.17, indicating that its share price is 117% more volatile than the S&P 500. Comparatively, MyMD Pharmaceuticals has a beta of 2.15, indicating that its share price is 115% more volatile than the S&P 500. SummaryPetros Pharmaceuticals beats MyMD Pharmaceuticals on 8 of the 10 factors compared between the two stocks. Get MyMD Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for MYMD and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart MYMD vs. The Competition Export to ExcelMetricMyMD PharmaceuticalsDiagnostic substances IndustryMedical SectorNASDAQ ExchangeMarket Cap$434,000.00$2.30B$5.31B$7.35BDividend YieldN/A0.79%5.12%4.30%P/E RatioN/A6.9321.8617.80Price / SalesN/A46.40380.5497.75Price / CashN/A15.7538.2634.64Price / Book0.032.936.453.98Net Income-$4M-$65.73M$3.22B$247.81M7 Day Performance-28.85%-4.94%2.85%1.80%1 Month Performance-50.22%-19.80%-8.67%-6.97%1 Year Performance-92.67%-17.97%11.46%1.30% MyMD Pharmaceuticals Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)MYMDMyMD PharmaceuticalsN/A$0.18-25.4%N/A-89.1%$434,000.00N/A0.006High Trading VolumePTPIPetros Pharmaceuticals0.2771 of 5 stars$0.05flatN/A-94.1%$2.46M$5.11M-0.0120Short Interest ↑Gap DownTHARTharimmune2.1851 of 5 stars$1.15-2.1%$17.00+1,378.3%-80.1%$2.43MN/A-0.122Short Interest ↑QLGNQualigen TherapeuticsN/A$3.29+6.0%N/A-78.4%$2.42M$4.98M0.0050Short Interest ↑Gap DownGLMDGalmed Pharmaceuticals1.0874 of 5 stars$1.41+6.0%N/A-67.8%$2.33MN/A-0.0820Short Interest ↑News CoverageVCNXVaccinexN/A$0.87+26.1%N/A-84.7%$2.26M$388,000.00-0.0240PBMPsyence BiomedicalN/A$0.49+4.7%N/A-99.1%$2.24MN/A0.00N/ANews CoverageGap UpPTIXProtagenic Therapeutics1.5667 of 5 stars$0.29-6.8%N/A-82.2%$2.17MN/A-0.232Short Interest ↓Positive NewsGap DownELABElevai Labs0.4746 of 5 stars$2.91-8.5%N/A-99.7%$2.06M$2.45M-0.0518Short Interest ↑ZVSAZyVersa Therapeutics0.9731 of 5 stars$0.78-8.3%N/A-88.0%$2.00MN/A0.002Short Interest ↓ENTOEntero Therapeutics0.5788 of 5 stars$0.40-1.7%N/AN/A$1.91MN/A0.009Positive NewsGap Down Related Companies and Tools Related Companies PTPI Alternatives THAR Alternatives QLGN Alternatives GLMD Alternatives VCNX Alternatives PBM Alternatives PTIX Alternatives ELAB Alternatives ZVSA Alternatives ENTO Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:MYMD) was last updated on 4/18/2025 by MarketBeat.com Staff From Our PartnersTrump’s Secret WeaponHave you looked at the stock market recently? Millions of investors are scrambling trying to figure out what's...American Alternative | SponsoredElon Reveals Why There Soon Won’t Be Any Money For Social SecurityElon Musk's Near-Death Experience Sparks Dire Warning for Americans After cheating death twice—once in a te...Colonial Metals | SponsoredTrump’s Bitcoin Reserve is No Accident…Bryce Paul believes this is the #1 coin to buy right now The catalyst behind this surge is a massive new b...Crypto 101 Media | Sponsored100-year-old investment secret predicts what?!A 100-year-old indicator has quietly predicted nearly every major market meltdown — including the Dot-Com Bust...Weiss Ratings | SponsoredThe first casualty of the 2025 trade warThe headlines scream tariffs and export bans — but the real damage is happening in retirement portfolios. Tim ...Investors Alley | SponsoredHow War with China Could Start in 128 DaysThe clock is ticking. Those who aren't prepared could lose everything. I've identified 43 investments we...Behind the Markets | SponsoredMy prediction is coming trueWe've developed a surprisingly effective way to see which stocks could double during massive shake-ups, by usi...InvestorPlace | Sponsored🥾⛏️👷♂️ What I Learned From Numerous Mine Visits...Twenty years ago, I made a decision that changed my life. Instead of sitting behind a desk analyzing mining...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding MyMD Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share MyMD Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy MYMD Stock Free MYMD Stock Alerts